Canada must renew leadership on antimicrobial resistance

AMR is rendering the global antibiotic arsenal ineffective. Left unchecked, it will lead to the collapse of Canadian health systems. Without a final national action plan, Canada will remain ill-prepared to combat this growing threat.

Testing the susceptibility of Staphylococcus aureus to antibiotics by the Kirby-Bauer disk diffusion method. The federal government should work to pass regulatory reforms to help accelerate the approval and market launch of newly developed antibiotics. Ultimately, while learning from international best practices is important, Canada needs to develop a 'made-in Canada' approach well-suited to our unique health care systems, taking into account our federal, provincial and territorial components.Image courtesy of Wikimedia Commons

Opinion

BY DANI PETERS, PAMELA FRALICK, & MICHAEL HODIN

October 3, 2022

Antimicrobial resistance poses a dire threat not only to the future of public health, but also to the economic prosperity of Canada and the entire world. Just before COVID-19 hit, the Public Health Agency of Canada sponsored a first-ever national-level study on the socio-economic impact of antimicr...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy